Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXAFA trial of apixaban versus vitamin K antagonist during atrial fibrillation ablation
NL-OMON44975Phase 4Active, not recruiting
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of apixaban in Atrial fibrillation (AFib), sponsored by Kompetenznetz Vorhofflimmern. Started Sep 2015; status: active, not recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON44975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44975.